investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Investigation of the ABC Half-Transporter ABCG2
Susan Bates
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
We aim to understand structure/function relationships in the ABC transporter ABCG2.
Related projects
Xiaosong Wang
CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER
Breast
Ruth E Malone
Investigating Institutional Influences on Tobacco Control
Trachea, bronchus and lung
Philip N. Tsichlis
Differential regulation of RNA processing by Akt isoforms
Trachea, bronchus and lung
Pathology
Shridar Ganesan
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
Breast
Marcus E Peter
Fas protects cancer stem cells from death
Breast
Martin Mcmahon
Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models
Trachea, bronchus and lung
Pathology
Martin Mcintosh
Profiling cancer neoantigen repertoires and validating immunotherapy targets
Trachea, bronchus and lung
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Alison Motsinger-Reif
Genetic Etiology of Cancer Drug Response
Breast